• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CVRX, INC. BAROSTIM NEO; IMPLANTABLE PULSE GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CVRX, INC. BAROSTIM NEO; IMPLANTABLE PULSE GENERATOR Back to Search Results
Model Number 2102
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Myocardial Infarction (1969); Skin Inflammation/ Irritation (4545)
Event Date 05/21/2021
Event Type  Injury  
Manufacturer Narrative
Interviews with the surgeon and cardiologist confirm that the patient's underlying cardiac condition and history along with the anesthesia regimen likely resulted in the nstemi and mi is an identified inherent risk associated with the use of the system.These interviews also confirmed that a desire to restart anticoagulant therapy soon after the implant procedure resulted in the prolonged hospitalization to monitor the swelling in the patient's neck prior to release.Both concerns were reported to have completely resolved.
 
Event Description
Patient was implanted on (b)(6) 2021 with the barostim neo system.On or about (b)(6) 2021 the patient experienced a non-st segment elevation myocardial infarction (nstemi) which was managed with nitroglycerin and did not require catheterization.The surgeon and cardiologist attributed this to the anesthesia regimen for the implant procedure.The patient was reported to have an extensive cardiac history including past nstemi events.Patient was hospitalized until (b)(6) 2021 but not due to the nstemi.This was reportedly due to additional swelling at the neck incision site related to restarting of anticoagulation therapy soon after the procedure.All events were reportedly addressed and felt to resolve quickly with medical management on the floor and did not require additional invasive procedures.Cvrx was not made aware of this event until (b)(6) 2021.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAROSTIM NEO
Type of Device
IMPLANTABLE PULSE GENERATOR
Manufacturer (Section D)
CVRX, INC.
9201 west broadway avenue
suite 650
minneapolis MN 55445
Manufacturer (Section G)
CVRX, INC.
9201 west broadway avenue
suite 650
minneapolis MN 55445
Manufacturer Contact
al crouse
9201 west broadway avenue
suite 650
minneapolis, MN 55445
7634167457
MDR Report Key12177914
MDR Text Key261908451
Report Number3007972010-2021-00002
Device Sequence Number1
Product Code DSR
UDI-Device Identifier00859144004432
UDI-Public(01)00859144004432(17)220618
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180050
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Remedial Action Patient Monitoring
Type of Report Initial
Report Date 07/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/15/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/18/2022
Device Model Number2102
Device Catalogue Number100054-202
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/16/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/18/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age59 YR
Patient Weight75
-
-